AVEO Pharmaceuticals, Inc.
Overview
AVEO Pharmaceuticals, Inc. is a biopharmaceutical company dedicated to advancing targeted medicines for oncology and other areas of unmet need. In January 2023, AVEO became a wholly-owned subsidiary of LG Chem, a global chemical company.
Therapeutic areas
FDA compliance signals
No FDA recalls, Warning Letters, or Form 483 observations are linked to AVEO Pharmaceuticals, Inc. in our records. Events are linked by company name and identifier, so this is not proof that none exist; check the FDA's own databases before relying on it.
Is this AVEO Pharmaceuticals, Inc.?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.
Need suppliers found and checked?
The Sourcing Desk turns these records into a checked shortlist: current filings, site, grade and regulatory history confirmed for your product, for a buyer-paid fixed fee and no supplier commission.